Catalysts for Venclexta
22 tracked
Apr 30, 2026
phase 1 2 completion
AbbVie Inc — venetoclax (Phase I/II Trial Completion)
venetoclax
→
Apr 29, 2026
phase 3 initiation
Institute of Hematology and Blood Diseases Hospital — venetoclax (Phase III Trial Initiation)
venetoclax
→
Feb 19, 2026
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Jun 15, 2022
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Oct 22, 2021
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Oct 4, 2021
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Nov 19, 2020
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Oct 16, 2020
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Oct 16, 2020
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Jun 12, 2020
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
May 29, 2020
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Jul 25, 2019
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Jul 25, 2019
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Jul 25, 2019
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
May 15, 2019
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Nov 21, 2018
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Sep 7, 2018
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Sep 7, 2018
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Jun 8, 2018
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Jun 8, 2018
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Dec 20, 2017
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Apr 11, 2016
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→